Search bioRxiv⌕ Search

Biology subjects

Li, W.-T.

Publications and source records attributed to Li, W.-T..

2 recordsLinked to original sources

Nir1-Nir2 Heterodimerization Confers Robustness to the Phosphoinositide Cycle

The phosphatidylinositol (PI) cycle sustains phosphoinositide-calcium signaling by replenishing plasma membrane phosphatidylinositol 4,5-bisphosphate (PIP2) consumed during receptor activation. Recruitment of the lipid transfer protein Nir2 to endoplasmic reticulum (ER)-plasma membrane (PM) contact sites (also known as ER-PM junctions) is central to this process, enabling transfer of PI from the ER to the PM for PIP2 resynthesis. Although the disease-associated Nir2 paralog Nir1 is essential for Nir2 recruitment under physiological conditions, the molecular basis of this regulation has remained unresolved. Here, we identify a conserved Nir Dimerization (NirD) domain in both Nir1 and Nir2 and determine the crystal structures. We show that NirD mediates preferential Nir1-Nir2 heterodimerization, which promotes Nir2 recruitment to ER-PM junctions and enhances PIP2 replenishment in stimulated cells. Furthermore, Nir1-Nir2 heterodimerization confers stimulus-strength-dependent, graded recruitment of Nir2, thereby broadening the sensitivity and dynamic range of PI cycle activity. Together, our findings uncover the structural mechanism underlying Nir1-dependent regulation of Nir2 and reveal paralog heterodimerization as a key strategy for scaling lipid transport at membrane contact sites to signaling demand, ensuring robust phosphoinositide homeostasis.

cell biology↗

Do-it-yourself de novo antibody sequencing workflow that achieves complete accuracy of the variable regions

Antibodies are widely used as research tools or therapeutic agents. Knowing the sequences of the variable regions of an antibody--both the heavy chain and the light chain--is a prerequisite for the production of recombinant antibodies. Mass spectrometry-based de novo sequencing is a frequently used, and sometimes the only approach to gaining this information. Here, we describe a workflow that enables accurate sequence determination of monoclonal antibodies based on mass spectrometry data and freely available software tools. This workflow, which we developed using a homemade anti-FLAG monoclonal antibody as a reference sample, achieved 100% accuracy of the variable regions with clear distinction between leucine (L) and isoleucine (I). Using this workflow, we successfully decoded a monoclonal anti-HA antibody, for which we had no prior knowledge of its sequence. Based on the de novo sequencing result, we generated a recombinant anti-HA antibody, and demonstrated that it has the same specificity, sensitivity, and affinity as the commercial antibody. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=142 SRC="FIGDIR/small/630060v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@180c502org.highwire.dtl.DTLVardef@1064399org.highwire.dtl.DTLVardef@4005d3org.highwire.dtl.DTLVardef@13e65ed_HPS_FORMAT_FIGEXP M_FIG C_FIG

biochemistry↗